Overview
Naiyer Rizvi is an Oncologist in New York, New York. Dr. Rizvi is highly rated in 11 conditions, according to our data. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Gamma Knife Radiosurgery.
His clinical research consists of co-authoring 110 peer reviewed articles and participating in 21 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
Locations
1275 York Ave, New York, NY 10065
161 Fort Washington Ave Fl 3, New York, NY 10032
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
21 Clinical Trials
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Alison Moskowitz is a Hematologist and an Oncologist in New York, New York. Dr. Moskowitz is highly rated in 33 conditions, according to our data. Her top areas of expertise are T-Cell Lymphoma, Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Moskowitz is currently accepting new patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Steven Horwitz is a Hematologist and an Oncologist in New York, New York. Dr. Horwitz is highly rated in 26 conditions, according to our data. His top areas of expertise are Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, and Bone Marrow Aspiration. Dr. Horwitz is currently accepting new patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Gilles Salles is a Hematologist and an Oncologist in New York, New York. Dr. Salles is highly rated in 27 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, Bone Marrow Transplant, and Splenectomy. Dr. Salles is currently accepting new patients.
Frequently Asked Questions about Dr. Naiyer Rizvi
How do I make an appointment with Dr. Naiyer Rizvi?
You can book an appointment with Dr. Naiyer Rizvi by calling their office at 212-639-2000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Naiyer Rizvi a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Naiyer Rizvi is classified as an Elite expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Naiyer Rizvi specialize in?
While Dr. Naiyer Rizvi is a Oncology, they have specific expertise in Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Lung Adenocarcinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Naiyer Rizvi participate in research or clinical trials?
Yes. Dr. Naiyer Rizvi has published 110 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Dr. Naiyer Rizvi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Naiyer Rizvi accept my insurance?
Dr. Naiyer Rizvi accepts most major insurance plans, including UnitedHealthcare. We recommend calling the office directly at 212-639-2000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Lung CancerDr. Rizvi isElite. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Rizvi isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Rizvi isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Rizvi isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Rizvi isDistinguished. Learn about Lung Adenocarcinoma.
- Pleuropulmonary BlastomaDr. Rizvi isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Rizvi isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- MelanomaDr. Rizvi isAdvanced. Learn about Melanoma.
- Experienced
- Anal CancerDr. Rizvi isExperienced. Learn about Anal Cancer.
- Gamma Knife RadiosurgeryDr. Rizvi isExperienced. Learn about Gamma Knife Radiosurgery.
- Gastrointestinal Stromal TumorDr. Rizvi isExperienced. Learn about Gastrointestinal Stromal Tumor.
- Gliomatosis CerebriDr. Rizvi isExperienced. Learn about Gliomatosis Cerebri.
- Hairy Cell Leukemia (HCL)Dr. Rizvi isExperienced. Learn about Hairy Cell Leukemia (HCL).
- Lung NodulesDr. Rizvi isExperienced. Learn about Lung Nodules.